References
Wise, R., Andrews, J. M., Edwards, L. J.: In vitro activity of Bay 09867, a new quinolone derivative, compared with those of other antimicrobial agents. Antimicrobial Agents and Chemotherapy 1983, 23: 559–564.
Hoogkamp-Korstanje, J. A. A.: Comparative in vitro activity of five quinolone derivatives and five other antimicrobial agents used in oral therapy. European Journal of Clinical Microbiology 1984, 3: 333–338.
Wingender, W., Graefe, K., II, Gau, W., Forster, D., Beermann, D., Schacht, P.: Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers. European Journal of Clinical Microbiology 1984, 3: 355–359.
Wise, R., Lockley, M. R., Crump, B., Adhami, Z. N.: The parmacokinetics and tissue penetration of orally administered enoxacin, norfloxacin and ciprofloxacin. Research and Clinical Forums 1985, 7: 63–68.
Medical Research Council: Definition — classification of chronic bronchitis for clinical and epidemiological purposes. Lancet 1965, i: 776.
Chapman, S. T., Speller, D. C. E., Reeves, D. S.: Resistance to ciprofloxacin. Lancet 1985, ii: 39.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Finch, R., Whitby, M., Craddock, C. et al. Clinical evaluation of treatment with ciprofloxacin. Eur. J, Clin. Microbiol. 5, 257–259 (1986). https://doi.org/10.1007/BF02014005
Issue Date:
DOI: https://doi.org/10.1007/BF02014005